Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Published in: Current Cardiology Reports 6/2015

01-06-2015 | Interventional Cardiology (S Rao, Section Editor)

Stenting of Coronary Bifurcation Lesions: a Literature and Technical Review

Authors: Joo Myung Lee, Kyung Woo Park, Bon-Kwon Koo, Hyo-Soo Kim

Published in: Current Cardiology Reports | Issue 6/2015

Login to get access

Abstract

Newer generation drug-eluting stents have improved outcomes in various subsets of coronary lesions including bifurcation lesions. This article reviews the current literature on various issues in bifurcation percutaneous coronary intervention (PCI). Generally, the provisional approach of placing one stent in the main vessel is the preferred first-line treatment for most bifurcation lesions. However, some lesions require 2-stenting. It is unknown whether 2nd-generation DES have improved outcomes with 2-stenting. The use of fractional flow reserve (FFR) for the assessment of functional significance of the jailed side branch can help avoid unnecessary stenting in complex lesions. Skilled techniques in every step of the 2-stenting process and meticulous use of imaging techniques including IVUS or OCT are warranted to obtain optimal angiographic and clinical results. Dedicated bifurcation stents are feasible treatment options and may change future concepts in bifurcation PCI, although larger trials with control groups are required in order to widely apply these techniques into daily routine practice.
Literature
1.
Steigen TK, Maeng M, Wiseth R, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic Bifurcation Study. Circulation. 2006;114:1955–61.CrossRefPubMed
2.••
Latib A, Colombo A. Bifurcation disease: what do we know, what should we do? JACC Cardiovasc Interv. 2008;1:218–26. This review article provides a comprehensive insights about bifurcation PCI. CrossRefPubMed
3.
Colombo A, Bramucci E, Sacca S, et al. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study. Circulation. 2009;119:71–8.CrossRefPubMed
4.
Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004;109:1244–9.CrossRefPubMed
5.
Ferenc M, Gick M, Kienzle RP, et al. Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions. Eur Heart J. 2008;29:2859–67.CrossRefPubMedCentralPubMed
6.
Hildick-Smith D, de Belder AJ, Cooter N, et al. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies. Circulation. 2010;121:1235–43.CrossRefPubMed
7.
Maeng M, Holm NR, Erglis A, et al. Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results. J Am Coll Cardiol. 2013;62:30–4.CrossRefPubMed
8.
Pan M, de Lezo JS, Medina A, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J. 2004;148:857–64.CrossRefPubMed
9.
Song YB, Hahn JY, Yang JH, et al. Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II. JACC Cardiovasc Interv. 2014;7:255–63.CrossRefPubMed
10.
Behan MW, Holm NR, Curzen NP, et al. Simple or complex stenting for bifurcation coronary lesions: a patient-level pooled-analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study. Circ Cardiovasc Interv. 2011;4:57–64.CrossRefPubMed
11.
Zhang F, Dong L, Ge J. Simple versus complex stenting strategy for coronary artery bifurcation lesions in the drug-eluting stent era: a meta-analysis of randomised trials. Heart. 2009;95:1676–81.CrossRefPubMed
12.
Zimarino M, Corazzini A, Ricci F, Di Nicola M, De Caterina R. Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a meta-analysis of randomized and observational studies. JACC Cardiovasc Interv. 2013;6:687–95.CrossRefPubMed
13.
Gao XF, Zhang YJ, Tian NL, et al. Stenting strategy for coronary artery bifurcation with drug-eluting stents: a meta-analysis of nine randomised trials and systematic review. EuroIntervention. 2014;10:561–9.CrossRefPubMed
14.
Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541–619.CrossRefPubMed
15.
Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58:e44–122.CrossRefPubMed
16.
Palmerini T, Biondi-Zoccai G, Della Riva D, et al. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2013;62:496–504.CrossRefPubMed
17.
Palmerini T, Biondi-Zoccai G, Della Riva D, et al. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2014;63:299–307.CrossRefPubMed
18.
Kang SH, Park KW, Kang DY, et al. Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis. Eur Heart J. 2014;35:1147–58.CrossRefPubMed
19.
Burzotta F, Trani C, Todaro D, et al. Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach. JACC Cardiovasc Interv. 2011;4:327–35.CrossRefPubMed
20.
Pan M, Medina A, Suarez de Lezo J, et al. Randomized study comparing everolimus- and sirolimus-eluting stents in patients with bifurcation lesions treated by provisional side-branch stenting. Catheter Cardiovasc Interv. 2012;80:1165–70.CrossRefPubMed
21.
Ormiston JA, Webster MW, El Jack S, et al. Drug-eluting stents for coronary bifurcations: bench testing of provisional side-branch strategies. Catheter Cardiovasc Interv. 2006;67:49–55.CrossRefPubMed
22.
Mortier P, Van Loo D, De Beule M, et al. Comparison of drug-eluting stent cell size using micro-CT: important data for bifurcation stent selection. EuroIntervention. 2008;4:391–6.CrossRefPubMed
23.
Basalus MW, van Houwelingen KG, Ankone MJ, Feijen J, von Birgelen C. Micro-computed tomographic assessment following extremely oversized partial postdilatation of drug-eluting stents. EuroIntervention. 2010;6:141–8.CrossRefPubMed
24.
Foin N, Alegria-Barrero E, Torii R, et al. Crush, culotte, T and protrusion: which 2-stent technique for treatment of true bifurcation lesions?—insights from in vitro experiments and micro-computed tomography. Circ J. 2013;77:73–80.CrossRefPubMed
25.
Basalus MW, Ankone MJ, van Houwelingen GK, de Man FH, von Birgelen C. Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. EuroIntervention. 2009;5:157–65.CrossRefPubMed
26.
Foin N, Sen S, Allegria E, et al. Maximal expansion capacity with current DES platforms: a critical factor for stent selection in the treatment of left main bifurcations? EuroIntervention. 2013;8:1315–25.CrossRefPubMed
27.
Toledano Delgado FJ, Alvarez-Ossorio MP, de Lezo Cruz-Conde JS et al. Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent. Catheter Cardiovasc Interv 2014;84(5):720–6.
28.
Yazdani SK, Nakano M, Otsuka F, Kolodgie FD, Virmani R. Atheroma and coronary bifurcations: before and after stenting. EuroIntervention. 2010;6(Suppl J):J24–30.CrossRefPubMed
29.
Burzotta F, Mortier P, Trani C. Characteristics of drug-eluting stent platforms potentially influencing bifurcated lesion provisional stenting procedure. EuroIntervention. 2014;10:124–32.CrossRefPubMed
30.
Yoshimura T, Tanaka A, Mori N, et al. Difference of neointimal growth patterns in bifurcation lesions among four kinds of drug-eluting stents: an optical coherence tomographic study. Catheter Cardiovasc Interv. 2014;84(5):742–9.CrossRefPubMed
31.
Garg S, Wykrzykowska J, Serruys PW, et al. The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer. EuroIntervention. 2011;6:928–35.CrossRefPubMed
32.
Diletti R, Garcia-Garcia HM, Bourantas CV, et al. Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial. Heart. 2013;99:1267–74.CrossRefPubMed
33.
Dzavik V, Kaul U, Guagliumi G, et al. Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: a report from the SPIRIT V single arm study. Catheter Cardiovasc Interv. 2013;82:E163–72.CrossRefPubMed
34.
Chen SL, Santoso T, Zhang JJ, et al. A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial. J Am Coll Cardiol. 2011;57:914–20.CrossRefPubMed
35.
Ruiz-Salmeron RJ, Valenzuela LF, Perez I, et al. Approach to coronary bifurcation lesions using the everolimus-eluting stent: comparison between a simple strategy and a complex strategy with T-stenting. Rev Esp Cardiol. 2013;66:636–43.CrossRefPubMed
36.
37.••
Moussa ID. Coronary artery bifurcation interventions: the disconnect between randomized clinical trials and patient centered decision-making. Catheter Cardiovasc Interv. 2011;77:537–45. This review provides valuable insight regarding pitfalls of currently available evidences and practical considerations in real-world practice. CrossRefPubMed
38.
Hahn J-Y, Song YB, Yang JH et al. TCT-689 Impact of final kissing ballooning on stent expansion, apposition, and neointimal hyperplasia in coronary bifurcation lesions treated with 1-stent technique. J Am Coll Cardiol. 2012;60(17_S):B200.
39.••
Koo BK, De Bruyne B. FFR in bifurcation stenting: what have we learned? EuroIntervention. 2010;6(Suppl J):J94–8. This review article provides comprehensive insights about FFR for evaluation and management of bifurcation lesions.CrossRefPubMed
40.
Park SJ, Kim YH, Park DW, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv. 2009;2:167–77.CrossRefPubMed
41.
Kim JS, Hong MK, Ko YG, et al. Impact of intravascular ultrasound guidance on long-term clinical outcomes in patients treated with drug-eluting stent for bifurcation lesions: data from a Korean multicenter bifurcation registry. Am Heart J. 2011;161:180–7.CrossRefPubMed
42.
Zhang Y, Farooq V, Garcia-Garcia HM, et al. Comparison of intravascular ultrasound versus angiography-guided drug-eluting stent implantation: a meta-analysis of one randomised trial and ten observational studies involving 19,619 patients. EuroIntervention. 2012;8:855–65.CrossRefPubMed
43.
Hahn JY, Chun WJ, Kim JH, et al. Predictors and outcomes of side branch occlusion after main vessel stenting in coronary bifurcation lesions: results from the COBIS II Registry (COronary BIfurcation Stenting). J Am Coll Cardiol. 2013;62:1654–9.CrossRefPubMed
44.
Rahman S, Leesar T, Cilingiroglu M, et al. Impact of kissing balloon inflation on the main vessel stent volume, area, and symmetry after side-branch dilation in patients with coronary bifurcation lesions: a serial volumetric intravascular ultrasound study. JACC Cardiovasc Interv. 2013;6:923–31.CrossRefPubMed
45.
Hariki H, Shinke T, Otake H, et al. Potential benefit of final kissing balloon inflation after single stenting for the treatment of bifurcation lesions—insights from optical coherence tomography observations. Circ J. 2013;77:1193–201.CrossRefPubMed
46.
Chen SL, Xu B, Han YL, et al. Comparison of double kissing crush versus culotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study. J Am Coll Cardiol. 2013;61:1482–8.CrossRefPubMed
47.
Chen SL, Zhang JJ, Ye F, et al. Study comparing the double kissing (DK) crush with classical crush for the treatment of coronary bifurcation lesions: the DKCRUSH-1 Bifurcation Study with drug-eluting stents. Eur J Clin Investig. 2008;38:361–71.CrossRef
48.
Kervinen K, Niemela M, Romppanen H, et al. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results. JACC Cardiovasc Interv. 2013;6:1160–5.CrossRefPubMed
49.••
Sgueglia GA, Chevalier B. Kissing balloon inflation in percutaneous coronary interventions. JACC Cardiovasc Interv. 2012;5:803–11. This review provides detailed literature review and practical guide regarding kissing balloon inflation which is essential component of bifurcation PCI.CrossRefPubMed
50.
Chen SL, Ye F, Zhang JJ, et al. Intravascular ultrasound-guided systematic two-stent techniques for coronary bifurcation lesions and reduced late stent thrombosis. Catheter Cardiovasc Interv. 2013;81:456–63.CrossRefPubMed
51.
Morlacchi S, Chiastra C, Cutri E, et al. Stent deformation, physical stress, and drug elution obtained with provisional stenting, conventional culotte and Tryton-based culotte to treat bifurcations: a virtual simulation study. EuroIntervention. 2014;9:1441–53.CrossRefPubMed
52.
Naganuma T, Latib A, Basavarajaiah S, et al. The long-term clinical outcome of T-stenting and small protrusion technique for coronary bifurcation lesions. JACC Cardiovasc Interv. 2013;6:554–61.CrossRefPubMed
53.
Burzotta F, De Vita M, Sgueglia G, Todaro D, Trani C. How to solve difficult side branch access? EuroIntervention. 2010;6(Suppl J):J72–80.CrossRefPubMed
54.
Alegria-Barrero E, Foin N, Chan PH, et al. Optical coherence tomography for guidance of distal cell recrossing in bifurcation stenting: choosing the right cell matters. EuroIntervention. 2012;8:205–13.CrossRefPubMed
55.
Foin N, Torii R, Alegria E, et al. Location of side branch access critically affects results in bifurcation stenting: insights from bench modeling and computational flow simulation. Int J Cardiol. 2013;168:3623–8.CrossRefPubMed
56.
Ormiston JA, Webster MW, Webber B, Stewart JT, Ruygrok PN, Hatrick RI. The "crush" technique for coronary artery bifurcation stenting: insights from micro-computed tomographic imaging of bench deployments. JACC Cardiovasc Interv. 2008;1:351–7.CrossRefPubMed
57.
Murasato Y. Impact of three-dimensional characteristics of the left main coronary artery bifurcation on outcome of crush stenting. Catheter Cardiovasc Interv. 2007;69:248–56.CrossRefPubMed
58.
Dzavik V, Kharbanda R, Ivanov J, et al. Predictors of long-term outcome after crush stenting of coronary bifurcation lesions: importance of the bifurcation angle. Am Heart J. 2006;152:762–9.CrossRefPubMed
59.
Hoye A, Iakovou I, Ge L, et al. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. J Am Coll Cardiol. 2006;47:1949–58.CrossRefPubMed
60.
Adriaenssens T, Byrne RA, Dibra A, et al. Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes. Eur Heart J. 2008;29:2868–76.CrossRefPubMed
61.
Ormiston JA, Webster MW, Ruygrok PN, Stewart JT, White HD, Scott DS. Stent deformation following simulated side-branch dilatation: a comparison of five stent designs. Catheter Cardiovasc Interv. 1999;47:258–64.CrossRefPubMed
62.
Kawasaki T, Koga H, Serikawa T, et al. Impact of a prolonged delivery inflation time for optimal drug-eluting stent expansion. Catheter Cardiovasc Interv. 2009;73:205–11.CrossRefPubMed
63.
Koo BK, Kang HJ, Youn TJ, et al. Physiologic assessment of jailed side branch lesions using fractional flow reserve. J Am Coll Cardiol. 2005;46:633–7.CrossRefPubMed
64.
Koo BK, Park KW, Kang HJ, et al. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. Eur Heart J. 2008;29:726–32.CrossRefPubMed
65.
Kumsars I, Narbute I, Thuesen L, et al. Side branch fractional flow reserve measurements after main vessel stenting: a Nordic-Baltic Bifurcation Study III substudy. EuroIntervention. 2012;7:1155–61.CrossRefPubMed
66.
Chen SL, Ye F, Zhang JJ, et al. Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions: The DKCRUSH-VI (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI) Trial. JACC Cardiovasc Interv. 2015. doi:10.​1016/​j.​jcin.​2014.​12.​221.
67.
Stankovic G, Lefevre T, Chieffo A, et al. Consensus from the 7th European Bifurcation Club meeting. EuroIntervention. 2013;9:36–45.CrossRefPubMed
68.••
Latib A, Colombo A, Sangiorgi GM. Bifurcation stenting: current strategies and new devices. Heart. 2009;95:495–504. This comprehensive review provides detailed information regarding the dedicated bifurcation stents.CrossRefPubMed
69.
70.
Grundeken MJ, Asgedom S, Damman P, et al. Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies. EuroIntervention. 2013;9:195–203.CrossRefPubMed
71.
Buysschaert I, Dubois CL, Dens J, et al. Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study. EuroIntervention. 2013;9:573–81.CrossRefPubMed
Metadata
Title
Stenting of Coronary Bifurcation Lesions: a Literature and Technical Review
Authors
Joo Myung Lee
Kyung Woo Park
Bon-Kwon Koo
Hyo-Soo Kim
Publication date
01-06-2015
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 6/2015
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-015-0595-7

Other articles of this Issue 6/2015

Current Cardiology Reports 6/2015 Go to the issue

Echocardiography (JM Gardin, Section Editor)

Stress Echocardiography: What Is New and How Does It Compare with Myocardial Perfusion Imaging and Other Modalities?

Echocardiography (JM Gardin, Section Editor)

Echocardiographic Evaluation of Prosthetic Heart Valves

Echocardiography (JM Gardin, Section Editor)

Evaluation of Aortic Stenosis: an Update—Including Low-Flow States, Myocardial Mechanics, and Stress Testing

Cardiac PET, CT, and MRI (SE Petersen, Section Editor)

New Insights from Major Prospective Cohort Studies with Cardiovascular Magnetic Resonance (CMR)

New Therapies for Cardiovascular Disease (KW Mahaffey, Section Editor)

The Evolution of Temporary Percutaneous Mechanical Circulatory Support Devices: a Review of the Options and Evidence in Cardiogenic Shock

Diabetes and Cardiovascular Disease (S Malik, Section Editor)

Impact of Functional Foods on Prevention of Cardiovascular Disease and Diabetes

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits